- Home
- TENX vs LTRN Comparison
TENX vs LTRN Comparison
Compare TENX & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TENX | LTRN |
|---|---|---|
| Founded | 1967 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.2M | 49.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | TENX | LTRN |
|---|---|---|
| Price | $9.94 | $3.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $17.00 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 148.5K | 71.3K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.63 | $2.55 |
| 52 Week High | $10.55 | $6.12 |
Technical Indicators
Market Signals| Indicator | TENX | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 69.29 | 54.45 |
| Support Level | $9.40 | $3.72 |
| Resistance Level | $10.55 | $4.00 |
| Average True Range (ATR) | 0.59 | 0.28 |
| MACD | 0.09 | 0.06 |
| Stochastic Oscillator | 78.57 | 82.45 |
Price Performance
Historical ComparisonAbout TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.